Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer
2010 ◽
Vol 20
(3)
◽
pp. 571-580
◽
2010 ◽
Vol 316
(11)
◽
pp. 1896-1906
◽
2009 ◽
Vol 132
(6)
◽
pp. 633-638
◽
Keyword(s):
2007 ◽
Vol 53
(1)
◽
pp. 1-9
◽
2011 ◽
Vol 102
(10)
◽
pp. 1855-1861
◽
2009 ◽
Vol 21
(5)
◽
pp. 565-569
◽